London, UK - ValiRx Plc (AIM: VAL), a life sciences company focusing on early-stage cancer therapeutics and women's health, announces that, further to the announcement made on 30 October 2025, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results